Price to Earning ratio Analysis of Aarti Pharmalabs Ltd. - Deep Dive
Latest FY PE
Period Ending - Mar-25
Poor PE
24.93
Period Ending - Mar-24
Indecisive PE
18.18
Growth
37.13 %
Trailing Twelve Months PE
Period Ending - Mar-25
Very Poor PE
30.25
PE Analysis of Aarti Pharmalabs Ltd.
P/E Ratio of Aarti Pharmalabs Ltd. with value of 30.25 shows that stock price is high compared to company earnings and may be overvalued. |
PE Ratio of AARTIPHARM rose handsomely by 37.13 % this year. |
PE Ratio of AARTIPHARM trending up for at least three Years. |
PE Ratio with value of 0 was lowest in Year Mar-22 in last Five Years. |
Latest PE Ratio with value of 24.93 is Greater than Average PE of 11.20 in last five years. |
Other PE Related Info of AARTIPHARM that may interest you.
Aarti Pharmalabs Ltd. Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
AARTIPHARM | 909.25 | 925.25 | 1.73 % | Drugs & Pharma |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
Very Low Value Stock | Screener |
FY - Historical Price to Earning of Aarti Pharmalabs Ltd.
Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 |
---|---|---|---|---|---|---|
PE | 24.93 | 18.18 | 12.92 | 0 | 0 | 0 |
Change | 37.13 % | 40.68 % | ||||
Price | 749.25 | 434.95 | 275.85 | 0 | 0 | 0 |
Price Change | 72.26 % | 57.68 % |
FY Chart of Price to Earning of Aarti Pharmalabs Ltd.
Understanding Price to Earning
Value Investing eBook
Free PDF eBook on Value Investing
Value Investing eBook
Free PDF eBook on Value Investing